The Israeli company recalled some vials of the drug in July 2009, and the FDA recently sent the company a warning letter about violations found at its Irvine, Calif., plant, according to the report.
APP Pharmaceuticals and Hospira are both manufacturing and distributing propofol. The FDA allowed APP to import a similar European product earlier this year after the American Society of Anesthesiologists raised concerns over the shortage.
Read the Wall Street Journal’s report on the propofol shortage.
